CMO will generate cell-line and process development for GMP production of dual-targeting proteins.
Financing of $6 million was also closed. Seahorse Bioscience, which manufactures instruments and consumables for cell-based metabolic assays, acquired BioProcessors, which makes microplate-sized cards with six small bioreactors for bioprocess scale-up and optimization. The two...
Continuous manufacturing is finally gaining traction in the pharmaceutical industry, but development of the necessary production technologies is, fittingly, a continuous process. Ultimately, the drawn-out development work will deliver worthwhile results. Using continuous processing instead...
Brain cancer researchers have provided chemical engineers with a biological enzyme that could be key to completing a more eco-friendly manufacturing process for nylon.
Firm maintains acquisition will allow transition from technology platform operation to specialty pharma company.
Companies obtain sublicenses to patents in the fields of non-invasive sensing and automated ascepti solution transfer.
Company aims to produce 10 million doses per month of influenza vaccines.
Partnership will exploit nuclease technology to develop biosimilars.
Takeda Pharmaceutical acquired the Baxalta biologics manufacturing facility to use it for biologic products.
Disposal of NVI may include contract manufacturing for third parties.